Investor insights
Sectors invested in
Funding rounds participated in
$72M sweet spot round size
Most of their 11 investments are in rounds between $25M and $90M
Investor type
Basic info
Industry
Sectors
Date founded
2015
Investments made
CF PharmTech, Inc. raised $51M on July 1, 2020
Investors: 博远资本, SAIC Capital and Yuanming Capital
CANbridge Life Sciences Ltd. raised $98M on February 18, 2020
Investors: General Atlantic, WuXi AppTec, Tigermed, Hudson Bay Capital Management LP, RA Capital Management, L.P. and Yuanming Capital
Undisclosed raised $53M on June 26, 2018
Investors: 经纬创投（北京）投资管理顾问有限公司 and Yuanming Capital
Mevion Medical Systems raised $150M on June 14, 2018
Investors: Yuanming Capital
Ansun Biopharma, Inc. raised $85M on May 14, 2018
Investors: 经纬创投（北京）投资管理顾问有限公司, Lilly Asia Ventures, LYFE Capital, Sinopharm Capital 国药资本, Oceanpine Capital, 3E Bioventures Capital and Yuanming Capital
JW Therapeutics 药明巨诺 raised $90M on March 7, 2018
Investors: Juno Therapeutics, Inc., Temasek, Sequoia Capital China, WuXi AppTec and Yuanming Capital
CANbridge Life Sciences Ltd. raised $25M on May 23, 2017
Investors: WuXi AppTec, Qiming Venture Partners and Yuanming Capital
Ascentage Pharma raised $72M on December 26, 2016
Investors: Yuanming Capital
APTX raised $20M on January 28, 2016
Investors: Yuanming Capital
Ascentage Pharma raised $16M on August 14, 2015
Investors: Efung Capital and Yuanming Capital